Company / PP&E (Net)
BioLife Solutions, Inc. PP&E (Net) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$14.7M
FY2025
5-year range
$5.7M / $23.6M
FY2021-FY2025
Trend
+146.3%
vs FY2024
Sector context
#119 of 135
Health Care
What the data says
BioLife Solutions, Inc.'s pp&e (net) of $15M is lower than 88% of companies in the Health Care sector (FY2025). PP&E (Net) has fluctuated over the past 10 years, ranging from $1M in FY2018 to $24M in FY2022.
Based on SEC 10-K filings.
$15M in FY2025 with a 5-year CAGR of +7.8%.
Improved from $6M to $15M over the past 2 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -14.6%
- 5-Year CAGR
- +7.8%
- 10-Year CAGR
- -
Sector benchmark
Bottom 12% in Health CareTop 88% of 135This company $14.7M Sector average $1.4B
▼
-98.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +7.8%, indicating consistent growth.
- In FY2025, pp&e (net) increased 146.3% year-over-year.
- Ranks #119 out of 135 companies in the Health Care sector.
- Peak pp&e (net) was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 4.67 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $14.7M | +146.3% |
| FY2024 | $6.0M | +5.0% |
| FY2023 | $5.7M | -75.9% |
| FY2022 | $23.6M | +33.9% |
| FY2021 | $17.7M | +74.5% |
| FY2020 | $10.1M | +81.6% |
| FY2019 | $5.6M | +412.6% |
| FY2018 | $1.1M | -1.7% |
| FY2017 | $1.1M | -6.9% |
| FY2016 | $1.2M | -17.9% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026